Literature DB >> 9414295

DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function.

M C Heinrich1, M E Hoatlin, A J Zigler, K V Silvey, A C Bakke, W W Keeble, Y Zhi, C A Reifsteck, M Grompe, M G Brown, R E Magenis, S B Olson, G C Bagby.   

Abstract

Cells from individuals with Fanconi anemia (FA) arrest excessively in the G2/M cell cycle compartment after exposure to low doses of DNA cross-linking agents. The relationship of this abnormality to the fundamental genetic defect in such cells is unknown, but many investigators have speculated that the various FA genes directly regulate cell cycle checkpoints. We tested the hypothesis that the protein encoded by the FA group C complementing gene (FAC) functions to control a cell cycle checkpoint and that cells from group C patients (FA[C]) have abnormalities of cell cycle regulation directly related to the genetic mutation. We found that retroviral transduction of FA(C) lymphoblasts with wild-type FAC cDNA resulted in normalization of the cell cycle response to low-dose mitomycin C (MMC). However, when DNA damage was quantified in terms of cytogenetic damage or cellular cytotoxicity, we found similar degrees of G2/M arrest in response to equitoxic amounts of MMC in FA(C) cells as well as in normal lymphoblasts. Similar results were obtained using isogenic pairs of uncorrected, FAC- or mock-corrected (neo only) FA(C) cell lines. To test the function of other checkpoints we examined the effects of hydroxyurea (HU) and ionizing radiation on cell cycle kinetics of FA(C) and normal lymphoblasts as well as with isogenic pairs of uncorrected, FAC-corrected, or mock-corrected FA(C) cell lines. In all cases the cell cycle response of FA(C) and normal lymphoblasts to these two agents were identical. Based on these studies we conclude that the aberrant G2/M arrest that typifies the response of FA(C) cells to low doses of cross-linking agents does not represent an abnormal cell cycle response but instead represents a normal cellular response to the excessive DNA damage that results in FA(C) cells following exposure to low doses of cross-linking agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9414295

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  DNA replication is required To elicit cellular responses to psoralen-induced DNA interstrand cross-links.

Authors:  Y M Akkari; R L Bateman; C A Reifsteck; S B Olson; M Grompe
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

Authors:  Raphael Ceccaldi; Delphine Briot; Jérôme Larghero; Nadia Vasquez; Catherine Dubois d'Enghien; Delphine Chamousset; Maria-Elena Noguera; Quinten Waisfisz; Olivier Hermine; Corinne Pondarre; Thierry Leblanc; Eliane Gluckman; Hans Joenje; Dominique Stoppa-Lyonnet; Gérard Socié; Jean Soulier
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

3.  Natural gene therapy in monozygotic twins with Fanconi anemia.

Authors:  Anuj Mankad; Toshiyasu Taniguchi; Barbara Cox; Yassmine Akkari; R Keaney Rathbun; Lora Lucas; Grover Bagby; Susan Olson; Alan D'Andrea; Markus Grompe
Journal:  Blood       Date:  2006-01-05       Impact factor: 22.113

4.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

5.  Distinct cellular phenotype linked to defective DNA interstrand crosslink repair and homologous recombination.

Authors:  Aleksandra M Gorniewska; Katarzyna Kluzek; Lidia Gackowska; Izabela Kubiszewska; Malgorzata Z Zdzienicka; Aneta Bialkowska
Journal:  Mol Med Rep       Date:  2017-06-15       Impact factor: 2.952

6.  Loss of Faap20 Causes Hematopoietic Stem and Progenitor Cell Depletion in Mice Under Genotoxic Stress.

Authors:  Tingting Zhang; Andrew F Wilson; Abdullah Mahmood Ali; Satoshi H Namekawa; Paul R Andreassen; Amom Ruhikanta Meetei; Qishen Pang
Journal:  Stem Cells       Date:  2015-05-25       Impact factor: 6.277

7.  BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks.

Authors:  Pietro Pichierri; Annapaola Franchitto; Filippo Rosselli
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

Review 8.  Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights.

Authors:  Larry H Thompson; John M Hinz
Journal:  Mutat Res       Date:  2009-02-21       Impact factor: 2.433

9.  Functional defects in the fanconi anemia pathway in pancreatic cancer cells.

Authors:  Michiel S van der Heijden; Jonathan R Brody; Eike Gallmeier; Steven C Cunningham; David A Dezentje; Dong Shen; Ralph H Hruban; Scott E Kern
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 10.  BRCA-FA pathway as a target for anti-tumor drugs.

Authors:  Rachel Litman; Rigu Gupta; Robert M Brosh; Sharon B Cantor
Journal:  Anticancer Agents Med Chem       Date:  2008-05       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.